Alireza Atri, MD, PhD, describes the pathophysiology of Alzheimer’s disease (AD).
Testing for Early Diagnosis of Alzheimer’s Disease
Dr Atri lists the common screening tools used to form an AD diagnosis.
An expert explains the role biomarker testing plays when diagnosing a patient with AD.
Alireza Atri, MD, PhD, discusses aducanumab’s recent FDA approval for the treatment of AD.
Dr Atri explains how aducanumab plays a role in diagnostic evaluations for patients with AD.
Dr Atri continues his discussion on aducanumab and AD diagnostic evaluations.
Alireza Atri, MD, PhD, concludes with a discussion on how different testing methods impact the care of patients with AD.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Daridorexant Provides Relief for Insomnia in Women During Menopausal Transition
2
New Study Finds Link Between Gut Hormone GLP-1 and NMOSD Symptoms, Paving Way for Targeted Treatments
3
Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity
4
International Committee Publishes 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis
5
